For the Inventor, By the Inventor

Enter assignee name

Alligator Bioscience Ab

USPTO Granted Patents = 37

% Expired Patents = 43.2

EPO Patents = 13

Trademarks = 3

Forward Citations = 63

Loading Chart...

Loading Chart...

61 inventors (with patents filed for the assignee):

Peter Ellmark (19 out of 19 patents)

Christina Furebring (19 out of 19 patents)

Laura Von Schantz (13 out of 13 patents)

4. Sara Fritzell (10 out of 10 patents)

5. Laura Varas (9 out of 9 patents)

6. Niina Veitonmaki (9 out of 9 patents)

7. Anna Sall (7 out of 7 patents)

8. Per Norlen (6 out of 6 patents)

9. Eva Maria Dahlen (6 out of 6 patents)

10. Jessica Petersson (5 out of 5 patents)

11. Roland Carlsson (5 out of 13 patents)

12. Ann-Christin Malmborg Hager (5 out of 5 patents)

13. Karin Enell Smith (4 out of 4 patents)

14. Carl Borrebaeck (4 out of 4 patents)

15. David Bienvenue (3 out of 7 patents)

37 patents: Sort by Forward Citations

1. 12570759 - NOVEL POLYPEPTIDES (2026-03-10),

2. 12570753 - COMBINATION THERAPIES WITH ANTI CD40 ANTIBODIES (2026-03-10),

3. 12509526 - NOVEL ANTI-CD137 ANTIBODIES AND USES THEREOF (2025-12-30),

4. 12448465 - Peptides (2025-10-21),

5. 12415862 - Methods and compositions (2025-09-16),

6. 12173082 - Bispecific polypeptides against CD137 (2024-12-24),

7. 11873348 - Peptides (2024-01-16),

8. 11780928 - Polypeptides (2023-10-10),

9. 11725060 - Antigen binding proteins binding to 5T4 and 4-1BB and related compositions and methods (2023-08-15),

10. 11535678 - Anti-CD137 antibodies and uses thereof (2022-12-27),

11. 11312786 - Oncofetal antigen binding proteins and related compositions and methods (2022-04-26),

12. 11149090 - Combination therapies with anti CD40 antibodies (2021-10-19),

13. 11008396 - Polypeptides (2021-05-18),

14. 10774150 - Polypeptides (2020-09-15),

15. 10689454 - Anti-CD137 antibodies and uses thereof (2020-06-23),

Alligator Bioscience AB is a Swedish biotechnology company that specializes in developing innovative immune-oncology drugs for cancer treatment. The company's focus lies in the development of tumor-directed immunotherapies using advanced antibody-based drug discovery. Alligator Bioscience aims to improve cancer patients' lives by developing novel and effective therapeutics that stimulate the body's immune system to fight cancer. For more information, please visit their official website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Alligator Bioscience Ab

37 Patents

#16 in Lund

#188 in Sweden

#18,212 in the World

Alligator Bioscience Ab

Forward Citations = 63

61 inventors:

Peter Ellmark (19 out of 19 patents)

Christina Furebring (19 out of 19 patents)

Laura Von Schantz (13 out of 13 patents)

4. Sara Fritzell (10 out of 10 patents)

5. Laura Varas (9 out of 9 patents)

Please report any incorrect information to [email protected]

Loading…